Literature DB >> 6775958

Bile acids and their sulphated and glucuronidated derivatives in bile, plasma, and urine of children with intrahepatic cholestasis: effects of phenobarbital treatment.

A Stiehl, M Becker, P Czygan, W Fröhling, B Kommerell, H W Rotthauwe, M Senn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6775958     DOI: 10.1111/j.1365-2362.1980.tb00038.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  16 in total

1.  Separate transport systems for biliary secretion of sulfated and unsulfated bile acids in the rat.

Authors:  F Kuipers; M Enserink; R Havinga; A B van der Steen; M J Hardonk; J Fevery; R J Vonk
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 2.  Regulation of the cytosolic sulfotransferases by nuclear receptors.

Authors:  Melissa Runge-Morris; Thomas A Kocarek; Charles N Falany
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

3.  Upregulation of UGT2B4 Expression by 3'-Phosphoadenosine-5'-Phosphosulfate Synthase Knockdown: Implications for Coordinated Control of Bile Acid Conjugation.

Authors:  Kathleen G Barrett; Hailin Fang; Daniela Cukovic; Alan A Dombkowski; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Drug Metab Dispos       Date:  2015-05-06       Impact factor: 3.922

Review 4.  Clinical pharmacokinetics of therapeutic bile acids.

Authors:  A Crosignani; K D Setchell; P Invernizzi; A Larghi; C M Rodrigues; M Podda
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

5.  Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease).

Authors:  E Jacquemin; M Dumont; O Bernard; S Erlinger; M Hadchouel
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

6.  Sulphated bile acids in duodenal juice of healthy infants and children compared with sulphated bile acids in paediatric patients with various gastroenterological diseases.

Authors:  K H Niessen; M Teufel; G Brügmann
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

7.  Biliary lipid compositions in cholestatic diseases of infancy.

Authors:  Y Tazawa; M Yamada; M Nakagawa; T Konno; K Tada
Journal:  Arch Dis Child       Date:  1983-10       Impact factor: 3.791

8.  Urinary concentrations of bile acid glucuronides and sulfates in hepatobiliary diseases.

Authors:  H Takikawa; T Beppu; Y Seyama
Journal:  Gastroenterol Jpn       Date:  1984-04

9.  Lithocholate glucuronide is a cholestatic agent.

Authors:  D G Oelberg; M V Chari; J M Little; E W Adcock; R Lester
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

10.  Use of the conjugate of disulphated ursodeoxycholic acid with p-aminobenzoic acid for the detection of intestinal bacteria.

Authors:  M Takahashi; T Konishi; Y Maeda; Y Matsugu; F Akazawa; T Eto; M Okajima; K Uchida; Y Masaoka; K Okada
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.